| 000 | 01873 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514041125.0 | ||
| 264 | 0 | _c20030113 | |
| 008 | 200301s 0 0 eng d | ||
| 022 | _a0031-3998 | ||
| 024 | 7 |
_a10.1203/00006450-200208000-00025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPlecko, Barbara | |
| 245 | 0 | 0 |
_aOral beta-hydroxybutyrate supplementation in two patients with hyperinsulinemic hypoglycemia: monitoring of beta-hydroxybutyrate levels in blood and cerebrospinal fluid, and in the brain by in vivo magnetic resonance spectroscopy. _h[electronic resource] |
| 260 |
_bPediatric research _cAug 2002 |
||
| 300 |
_a301-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a3-Hydroxybutyric Acid _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aBlood Glucose |
| 650 | 0 | 4 | _aBrain Chemistry |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 |
_aFatty Acids, Nonesterified _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperinsulinism _xdrug therapy |
| 650 | 0 | 4 |
_aHypoglycemia _xdrug therapy |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aKetone Bodies _xanalysis |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 700 | 1 | _aStoeckler-Ipsiroglu, Sylvia | |
| 700 | 1 | _aSchober, Edith | |
| 700 | 1 | _aHarrer, Georg | |
| 700 | 1 | _aMlynarik, Vladimir | |
| 700 | 1 | _aGruber, Stephan | |
| 700 | 1 | _aMoser, Ewald | |
| 700 | 1 | _aMoeslinger, Dorothea | |
| 700 | 1 | _aSilgoner, Heinz | |
| 700 | 1 | _aIpsiroglu, Osman | |
| 773 | 0 |
_tPediatric research _gvol. 52 _gno. 2 _gp. 301-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1203/00006450-200208000-00025 _zAvailable from publisher's website |
| 999 |
_c12036624 _d12036624 |
||